Unknown

Dataset Information

0

Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.


ABSTRACT: Inflammatory mediators and metalloproteinases are altered in acute ischemic stroke (AIS) and play a detrimental effect on clinical severity and hemorrhagic transformation of the ischemic brain lesion. Using data from the Italian multicenter observational MAGIC (MArker bioloGici nell'Ictus Cerebrale) Study, we evaluated the effect of inflammatory and metalloproteinases profiles on three-month functional outcome, hemorrhagic transformation and mortality in 327 patients with AIS treated with intravenous thrombolys in according to SITS-MOST (Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy) criteria. Circulating biomarkers were assessed at baseline and 24?h after thrombolysis. Adjusting for age, sex, baseline glycemia and National Institute of Health Stroke Scale, history of atrial fibrillation or congestive heart failure, and of inflammatory diseases or infections, baseline alpha-2macroglobulin (A2M), baseline serum amyloid protein (SAP) and pre-post tissue-plasminogen activator (tPA) variations (?) of metalloproteinase 9, remained significantly and independently associated with three-month death [OR (95% CI):A2M:2.99 (1.19-7.53); SAP:5.46 (1.64-18.74); ?metalloproteinase 9:1.60 (1.12-2.27)]. The addition of baseline A2M and ?metalloproteinase 9 or baseline SAP and ?metalloproteinase 9 (model-2 or model-3) to clinical variables (model-1) significantly improved the area under curve for prediction of death [model-2 with A2M: p?=?0.0205; model-3 with SAP: p?=?0.001]. In conclusion, among AIS patients treated with thrombolysis, circulating A2M, SAP and ?metalloproteinase 9 are independent markers of poor outcome. These results may prompt controlled clinical research about agents antagonizing their effect.

SUBMITTER: Gori AM 

PROVIDER: S-EPMC5584701 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.

Gori Anna Maria AM   Giusti Betti B   Piccardi Benedetta B   Nencini Patrizia P   Palumbo Vanessa V   Nesi Mascia M   Nucera Antonia A   Pracucci Giovanni G   Tonelli Paolina P   Innocenti Eleonora E   Sereni Alice A   Sticchi Elena E   Toni Danilo D   Bovi Paolo P   Guidotti Mario M   Tola Maria Rosaria MR   Consoli Domenico D   Micieli Giuseppe G   Tassi Rossana R   Orlandi Giovanni G   Sessa Maria M   Perini Francesco F   Delodovici Maria Luisa ML   Zedde Maria Luisa ML   Massaro Francesca F   Abbate Rosanna R   Inzitari Domenico D  

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20170307 9


Inflammatory mediators and metalloproteinases are altered in acute ischemic stroke (AIS) and play a detrimental effect on clinical severity and hemorrhagic transformation of the ischemic brain lesion. Using data from the Italian multicenter observational MAGIC (MArker bioloGici nell'Ictus Cerebrale) Study, we evaluated the effect of inflammatory and metalloproteinases profiles on three-month functional outcome, hemorrhagic transformation and mortality in 327 patients with AIS treated with intrav  ...[more]

Similar Datasets

| S-EPMC4445323 | biostudies-literature
| S-EPMC10796830 | biostudies-literature
| S-EPMC6914757 | biostudies-literature
| S-EPMC9830637 | biostudies-literature
| S-EPMC6652740 | biostudies-literature
| S-EPMC10498063 | biostudies-literature
| S-EPMC7606819 | biostudies-literature
| S-EPMC9494598 | biostudies-literature
| S-EPMC10925869 | biostudies-literature
| S-EPMC6788486 | biostudies-literature